✦ LIBER ✦

Pharmacogenetics of acenocoumarol: CYP2C9, CYP2C19, CYP1A2, CYP3A4, CYP3A5 and ABCB1 gene polymorphisms and dose requirements

✍ Scribed by R. B. Saraeva; I. D. Paskaleva; E. Doncheva; C. B. Eap; V.S. Ganev

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacogenomics ofCYP2A6,CYP2B6,CYP2C19

✍ M. I. Veiga; S. Asimus; P. E. Ferreira; J. P. Martins; I. Cavaco; V. Ribeiro; T. 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 199 KB

The high prevalence of the poor and ultr

✍ Ya-Huei Liou; Chien-Ting Lin; Ying-Jye Wu; Lawrence Shih-Hsin Wu 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB

Polymorphisms of drug-metabolizing enzym

✍ Elena A. Gaikovitch; Ingolf Cascorbi; Przemyslaw M. Mrozikiewicz; Jürgen Brockmö 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 233 KB

Moclobemide, a substrate of CYP2C19 and

✍ Gram, Lars F.; Guentert, Theodor W.; Grange, Susan; Vistisen, Kirsten; BrÃ¸sen, 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 817 KB

Dose-dependent inhibition of CYP1A2, CYP

✍ U. Jeppesen; L. F. Gram; K. Vistisen; S. Loft; H. E. Poulsen; K. Brøsen 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 95 KB

Assessment of CYP2C19 genetic polymorphi

✍ K.-A. Kim; W.-K. Song; K.-R. Kim; J.-Y. Park 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB